Superior mesenteric vein and portal vein thrombosis in a patient with COVID-19: a rare case (original) (raw)
Related papers
Cureus, 2021
More than 122 million cases of COVID-19 infection have been documented, and hundreds of thousands are being added every day. Several co-morbidities are associated with COVID-19, among which hypercoagulability has garnered the attention of many doctors and researchers. Most cases of vascular thrombosis are noted in intensive care unit (ICU) patients with serious disease; among these, many cases of deep venous thrombosis and pulmonary embolism have been noted. A few cases of portal vein thrombosis have also been documented in ICU patients with severe COVID-19. Here, we present a case of a portal vein and superior mesenteric vein thrombosis in a patient with subclinical COVID-19 infection. Through this case report, we intend to increase the research horizon and wish to help diagnose co-morbidities associated with COVID-19 at an earlier stage.
Radiology Case Reports, 2021
Subacute mesenteric venous thrombosis (SMVT) is vascular complication commonly associated with hypercoagulability, resulting in abdominal pain and ischemia of intestines. We report a 44 y/o male without relevant history and COVID-19 disease who developed abdominal pain after onset of respiratory symptoms. Imaging studies demonstrated abnormal findings on doppler US and CT scan compatible with thrombotic disease, successfully treated with anticoagulation therapy. This case exemplifies the heterogeneous presentation of late thrombotic complications in COVID-19 and the relevance of prophylactic measures against hypercoagulability.
Acute portal vein thrombosis secondary to COVID-19: a case report
BMC Gastroenterology
BackgroundCOVID-19 pneumonia exhibits several extra-pulmonary complications.Case presentationA 23-year old, asthmatic male with coronavirus pneumonia developed with generalized, acute abdominal pain. Further evaluations revealed a mild ascites and portal vein thrombosis although the patient received proper anticoagulation therapy. Routine lab data regarding the secondary causes of portal vein thrombosis were normal.ConclusionWe speculated that the underlying cause of portal vein thrombosis in our case was coronaviruses. Therefore, clinicians should always consider thrombosis and other hypercoagulable diseases in patients with COVID-19.
COVID-19-Induced Mesenteric Thrombosis
Cureus
Gastrointestinal symptoms, such as diarrhea (most common among gastrointestinal symptoms), nausea/vomiting, anorexia, abdominal pain, abnormal liver enzymes, and pancreatitis, are being increasingly recognized in patients with coronavirus disease 2019 (COVID-19). Moreover, COVID-19 has also been implicated in coagulopathy, especially in patients with severe disease. Here, we report a case of acute intestinal ischemia secondary to superior mesenteric thrombosis in a young female patient with mild COVID-19.
Hepatic vein thrombosis in a child with COVID-19: clinical case
Sučasna pedìatrìâ. Ukraïna, 2022
Predisposition to venous thromboembolism is characteristic of SARS-CoV-2 infection, as thromboinflammation is one of the leading parts in the pathogenesis of COVID-19 and the cause of life-threatening conditions and death. We presented a clinical case of hepatic vein thrombosis in a 1-year-9-month-old girl with COVID-19 who met the MIS-C criteria. The girl was admitted to the hospital on the first day of the disease with complaints of repeated vomiting, fever up to 38.5-39°C, severe weakness, refusal to eat and drink, a slight cough. The severity of the patient's condition was due to fever and intoxication syndrome. There were manifestations of acute pharyngitis. In the first days we observed leukocytosis with neutrophilia, moderate lymphopenia, elevated levels of C-reactive protein, hypoalbuminemia, accelerated ESR. On admissiona rapid antigen test and PCR for SARS-CoV-2 were negative. Abdominal ultrasound revealed microthrombosis of the hepatic veins with inflammatory changes in the vessels, a small amount of free fluid in the abdominal cavity. Echocardiography detected the presence of fluid in the pericardial cavity. The level of D-dimer was increased to 943 ng/ml. Subsequently, COVID-19 was confirmed by serological testing. Conclusions. Thus, thrombosis of the veins of the internal organs, despite their rarity in childhood, can occur in COVID-19 and MIS-C and indicate thromboinflammation, which requires caution about their possible development and the correct diagnostic algorithm. Determination of the level of D-dimer and Doppler ultrasound examination of the abdominal cavity allows the diagnosis of thrombotic events in splanchnic organs in patients with COVID-19 and provide adequate treatment. The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.
A Rare Case With Arterial and Venous Thrombotic Complications After COVID-19
Background Recently, it has been reported that there is an increase in the incidence of arterial and venous thrombotic complications associated with severe COVID-19 disease. Studies have revealed the definition of COVID-19-associated coagulopathy as the underlying cause of these complications. With the emergence of hypercoagulability, systemic anticoagulant therapy was required at variable doses and durations in COVID-19 patients. Case Report: We present the case of a 79-year-old female patient who developed ischemic stroke, deep vein thrombosis, and acute pulmonary embolism, respectively, despite the use of anticoagulants since hospitalization for severe COVID-19 disease. Discussion Owing to SARS-CoV2 infection may be accompanied by comorbidities such as hypoxia, immobilization, active cancer, and obesity, close patient monitoring should be performed during the period of active disease and recovery. Conclusion The most important message to be taken from this case is that even in pa...
Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection
European Journal of Case Reports in Internal Medicine, 2020
A 52-year-old patient with SARS-CoV-2 was diagnosed with interstitial pneumonia and treated with darunavir/ritonavir, hydroxychloroquine, azithromycin and low molecular weight heparin (LMWH). After LMWH cessation, he developed superior mesenteric arterial thrombosis. An abdominal CT scan showed arterial thrombosis of vessels efferent of the superior mesenteric artery with bowel distension. COVID-19 may predispose to venous and arterial thromboembolism. Anticoagulation prophylaxis should be considered in hospitalized patients with COVID-19, and potential thromboembolism investigated in each symptomatic patient affected by SARS-CoV-2.
2021
Introduction: Novel coronavirus (COVID-19) infection is reportedly associated with a high risk of thromboembolic complications. This review provides an overview of the current knowledge about the management of venous thromboembolism in coronavirus disease. Methods: An online search of literature through PubMed and google scholar was done using the term “COVID-19”, “treatment”, “thromboembolism”, “antiplatelet”, “antithrombolytics” and “anticoagulants”. Articles were chosen for inclusion based on their relevance to coagulopathy and thrombosis in coronavirus disease and anticoagulant therapy. Reference lists were also reviewed to select additional relevant articles. Results: Average incidence of thromboembolism in hospitalized COVID-19 patients varied between 25-53%. D-dimer was the most frequent coagulopathy marker used to assess the severity of the disease. If there is any suspicion of deep vein thrombosis (DVT), diagnosis is primarily based on bedside clinical examinations and then...
Thromboembolism after COVID 19 – our experience with 6 cases
Albanian Journal of Trauma and Emergency Surgery
Background: The 2020 year was different. WHO announced a global pandemic and till now we have over 2 million fatality rate. The SARS CoV-2 virus causes acute respiratory viral infection and is associated with a wide range of complications. Aim: In this article we are representing six patients with deep venous and arterial thrombosis after Covid-19 and their treatment. Materials and Methods: The patients were treated successively by the Department of Vascular Surgery and the Department of Burns, Plastic, Reconstructive and Aesthetic Surgery of the "St. George" University Hospital, Medical University Plovdiv, Bulgaria. Results: Some of them were treated conservatively and others surgically. The localizations were upper and lower extremity and the hard palate. Amputation of the affected limb, soft tissue defects and conservative treatment was required. The arterial thrombosis were more than venous ones. All the patients were stable at discharge. Conclusion: After COVID-19 co...
Massive Pulmonary Thromboembolism in Patients with COVID-19; Report of Three Cases
Archives of Academic Emergency Medicine, 2020
COVID-19 is a novel infectious disease, which has challenged people all around the world. As of today, healthcare practitioners and researchers have made great effort to understand the characteristics and clinical presentations of the disease; however, the existing literature is still incomplete in this regard. A growing body of evidence indicates that coagulopathies and thromboembolic events are of utmost importance in COVID-19 patients and are related to poor prognosis. Here, we report three ICU admitted cases of COVID-19, in which massive pulmonary thromboembolism (PTE) occurred a few days after disease onset. Unfortunately, one of the patients did not survive and two were treated; one with thrombectomy and other with antithrombotic agents. It seems that severe cases of COVID-19 are at risk for developing PTE and in-charge physicians should be prepared and plan for anticoagulant prophylaxis using low-molecular-weight heparin (LMWH).